NCT06347263 Clinical and Radiographic Evaluation of Using the Entire Papilla Preservation Technique With and Without Autogenous Bone Graft and Injectable Platelet Rich Fibrin in Treatment of Periodontal Intraosseous Defects
| NCT ID | NCT06347263 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Isolated Intrabony Periodontal Defects in Patients With Periodontitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2024-04-12 |
| Primary Completion | 2025-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2024-04-12 with a primary completion date of 2025-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this Clinical trial is to evaluate the clinical and radiographic outcomes of using entire papilla preservation technique with and without autogenous bone and injectable platelet rich fibrin in treatment of isolated Intrabony defects in patients with stage III periodontitis.
Eligibility Criteria
Inclusion Criteria: 1. Patients with healthy systemic condition. 2. Adult patients (18 years old and older). 3. Patients with stage lll periodontitis, having one isolated intrabony defect with probing depth \>6mm, clinical attachment level\> 6mm and at least 4 mm intrabony component involving predominantly the interproximal area of the affected tooth. 4. Patients with full mouth plaque score\<20%. 5. Patients with full mouth bleeding score\<20%. 6. Compliance with good oral hygiene. 7. Patients accept 6-months follow-up period (cooperative patients). 8. Patients provide an informed consent. Exclusion Criteria: 1. Ongoing drug therapy that might have an impact on the clinical signs and symptoms of periodontitis. 2. One wall intrabony defect. 3. Defects that involve the buccal and lingual sites. 4. Smokers ˃ 10 cigarettes / day. 5. Pregnant and lactating females.
Contact & Investigator
Laila T Sedeek, Bachelor
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT06347263 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Isolated Intrabony Periodontal Defects in Patients With Periodontitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06347263 currently recruiting?
Yes, NCT06347263 is actively recruiting participants. Contact the research team at laila.taher@dentistry.cu.edu.eg for enrollment information.
Where is the NCT06347263 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06347263 clinical trial?
NCT06347263 is sponsored by Cairo University. The principal investigator is Laila T Sedeek, Bachelor at Cairo University. The trial plans to enroll 24 participants.